Severe obesity and low muscle mass and functio

Not Applicable

• Conditions: Study of sarcopenia prevalence in patients with severe obesity; Musculoskeletal Diseases

• Registration Number: ISRCTN16638723
• Lead Sponsor: Sociedad Española de Endocrinología y Nutrición

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2024-06-19
• Last Update Posted: 8 July 2024
• Study Completion: 2025-01-12

Recruitment & Eligibility

• Status: Ongoing
• Sex: All
• Target Recruitment: 480

Inclusion Criteria

1. Men and women aged between 18 and 65 years
2. Diagnosis of obesity with a body mass index greater than or equal to 35 kg/m2 with associated comorbidities or BMI >40 kg/m2
3. Able to give informed consent

Exclusion Criteria

1. Weight greater than 227kg (load capacity limit DXA Hologic-Horizon WI model)
2. End-stage renal disease
3. Liver cirrhosis more advanced than Child A
4. Congestive heart failure NYHA grade 3-4
5. Serious limitations of functional capacity that prevent moving to the vehicle with the densitometer
6. Pregnancy
7. History of previous bariatric surgery
8. Not capable of granting informed consent
9. Patient refusal to participate in the study

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Prevalence of sarcopenic obesity in people with severe obesity followed in Endocrinology and Nutrition outpatient clinics in reference centers for obesity treatment in Spain measured using patient records at the end of the study<br><br>